After a brief hiatus, we are pleased to present you with the latest edition of EwingCole’s Momentum. Since our last issue, our Science & Technology practice has helped our clients take on challenges big and small. Even before the start of the pandemic nearly three years ago, many of us have had the pleasure of enjoying a front-row seat as our clients develop life-saving technologies that are transforming healthcare as we know it.
This issue of Momentum demonstrates how we have grown as a firm parallel to the strides made in cell & gene therapy and the broader biopharmaceutical industry.
